These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21685758)

  • 21. Transient red-blood-cell morphological anomalies after acute liver dysfunction.
    Lesesve JF; Garçon L; Lecompte T
    Eur J Haematol; 2010 Jan; 84(1):92-3. PubMed ID: 19624719
    [No Abstract]   [Full Text] [Related]  

  • 22. [Infection as a cause of multiple organ failure. Definition, pathophysiology and diagnostic parameters].
    Schuster HP
    Anasth Intensivther Notfallmed; 1989 Aug; 24(4):206-11. PubMed ID: 2683847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting the course of sepsis: the next step?
    Knöbl P
    Crit Care Med; 2005 Feb; 33(2):450-2. PubMed ID: 15699856
    [No Abstract]   [Full Text] [Related]  

  • 24. [Mechanisms and evaluation of multiple organ and system failure after trauma].
    Fontes B; Poggetti RS
    Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(2):72-7. PubMed ID: 9008937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The current pathogenetic aspects of MODS in the sepsis patient].
    Dorobăţ C; Dorobăţ G
    Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):44-7. PubMed ID: 9455434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms.
    Joop K; Berckmans RJ; Nieuwland R; Berkhout J; Romijn FP; Hack CE; Sturk A
    Thromb Haemost; 2001 May; 85(5):810-20. PubMed ID: 11372673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-derived microparticles in haemostasis and vascular medicine.
    Burnier L; Fontana P; Kwak BR; Angelillo-Scherrer A
    Thromb Haemost; 2009 Mar; 101(3):439-51. PubMed ID: 19277403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sepsis. II. Complications and treatment of sepsis].
    Makovický P; Mokán M; Vladár L; Vrlík M
    Cas Lek Cesk; 1996 Oct; 135(19):614-6. PubMed ID: 8998803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superficial septic thrombophlebitis.
    Katz SC; Pachter HL; Cushman JG; Roccaforte JD; Aggarwal S; Yee HT; Nalbandian MM
    J Trauma; 2005 Sep; 59(3):750-3. PubMed ID: 16361925
    [No Abstract]   [Full Text] [Related]  

  • 30. Septicaemia and the prevention of multiorgan failure--the intensive care perspective.
    Crowley K; Phelan D
    Ir Med J; 1990 Sep; 83(3):121-4. PubMed ID: 2228536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. Comparison between sepsis and trauma.
    Kushimoto S; Gando S; Saitoh D; Ogura H; Mayumi T; Koseki K; Ikeda T; Ishikura H; Iba T; Ueyama M; Eguchi Y; Otomo Y; Okamoto K; Endo S; Shimazaki S;
    Thromb Haemost; 2008 Dec; 100(6):1099-105. PubMed ID: 19132236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heart-type fatty acid-binding protein is a useful marker for organ dysfunction and leptin alleviates sepsis-induced organ injuries by restraining its tissue levels.
    Yan GT; Lin J; Hao XH; Xue H; Zhang K; Wang LH
    Eur J Pharmacol; 2009 Aug; 616(1-3):244-50. PubMed ID: 19576209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial.
    Payen D; Mateo J; Cavaillon JM; Fraisse F; Floriot C; Vicaut E;
    Crit Care Med; 2009 Mar; 37(3):803-10. PubMed ID: 19237881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Severe sepsis and multiple organ failure in surgical patients in intensive care unit of oncological profile].
    Gorobets ES; Sviridova SP; Gromova EG; Lobanova ED; Mazurina OG; Pleskov AP; Sytov AV
    Anesteziol Reanimatol; 1997; (3):30-3. PubMed ID: 9289982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comment on hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit by Okabayashi et al.
    Zeerleder S; Voves C; Wuillemin WA
    Am J Hematol; 2005 Aug; 79(4):344. PubMed ID: 16044451
    [No Abstract]   [Full Text] [Related]  

  • 36. Relevance of measuring circulating microparticles during organ and stem-cell transplantation.
    Rank A
    Transplantation; 2011 Aug; 92(3):265-6. PubMed ID: 21730890
    [No Abstract]   [Full Text] [Related]  

  • 37. [Plasma contents of cytokines (TNF-alpha, IL-1 beta, IL-6) and their clearance during continuous hemofiltration in patients with sepsis and multiple organ failure].
    Timokhov VS; Iakovleva II; Kalashnikova EA; Ipat'eva EI
    Anesteziol Reanimatol; 1997; (3):59-62. PubMed ID: 9289991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Authors Reply.
    Souza AC; Yuen PS; Star RA
    Kidney Int; 2015 Oct; 88(4):915-6. PubMed ID: 26422627
    [No Abstract]   [Full Text] [Related]  

  • 39. [Permanent hemofiltration in patients with sepsis, persistent hemorrhage and multiorgan dysfunction syndrome].
    Timokhov VS; Iakovleva II
    Urologiia; 2000; (6):18-20. PubMed ID: 11186314
    [No Abstract]   [Full Text] [Related]  

  • 40. [Multiple organ failure related to disseminated intravascular coagulation].
    Kumon K
    Nihon Rinsho; 1993 Jan; 51(1):26-9. PubMed ID: 8433524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.